Unsupervised use of psilocybin, or “magic mushrooms,” has accelerated among all age groups in the United States, but especially among adolescents and people 30 and older, a new study found. “The ...

Body image can severely affect a person’s wellbeing, both physically and mentally, and researchers are close to understanding how psilocybin can help. Psilocybin’s effects on eating disorders (ED) ...

In April, Vail Health’s Behavioral Health Innovation Center will kick off the second of two studies aimed at targeting depression. The OPTIMIZE study will examine the impacts of psilocybin, the active ...

A pilot program on the benefits of synthetic psilocybin for mental health issues like post-traumatic stress disorder (PTSD) is set to begin this summer at Yale University in New Haven, Connecticut. A ...

Routines for seasonal affective disorder (SAD) may help combat the winter blues. ( NPR) High school students who experienced ...

This is a small study, and scientists still need to conduct more research to understand the longterm effects of psilocybin. Psilocybin is the active ingredient in magic mushrooms. In recent decades, ...

Psilocybin, the active psychedelic ingredient in magic mushrooms, has been proven to impact patients with depression positively. Vail Health’s OPTIMIZE study, which will administer doses of psilocybin ...

Psilocybe cyanescens mushrooms, which contain the active compound, psilocybin. Credit: Imperial College London / Thomas Angus Psilocybin, the active compound in magic mushrooms, may be at least as ...

Psilocybin - the active ingredient in “magic” mushrooms - is a more effective treatment for symptoms of depression than controls, providing further support for its potential as an antidepressant, ...

A small pilot study published in the journal Psychedelic Medicine suggests that psilocybin-assisted psychotherapy might help reduce depressive symptoms in people with bipolar II disorder who have not ...

The present study consisted of 95 participants with alcohol use disorder who were randomized to receive either psilocybin or the antihistamine diphenhydramine. The study lasted 36 weeks, and the ...

Richard Schaefer took part in a clinical trial of psilocybin as a treatment for addiction. (Photo courtesy of Richard Schaefer) It was a day like any other when Richard Schaefer entered a Madison ...